Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9757030rdf:typepubmed:Citationlld:pubmed
pubmed-article:9757030lifeskim:mentionsumls-concept:C0030567lld:lifeskim
pubmed-article:9757030lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:9757030lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:9757030lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:9757030lifeskim:mentionsumls-concept:C0006104lld:lifeskim
pubmed-article:9757030lifeskim:mentionsumls-concept:C0015684lld:lifeskim
pubmed-article:9757030lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:9757030lifeskim:mentionsumls-concept:C0243126lld:lifeskim
pubmed-article:9757030pubmed:issue1-2lld:pubmed
pubmed-article:9757030pubmed:dateCreated1998-12-10lld:pubmed
pubmed-article:9757030pubmed:abstractTextFollowing pulse labeling with [3H]arachidonic acid ([3H]AA), its incorporation pattern in brain reflects regional changes in neurotransmitter signal transduction using phospholipase A2, that is, functional activity. In a rat model of Parkinson's disease, unilateral 6-hydroxydopamine lesion in the substantia nigra, [3H]AA acid incorporation from blood was increased in cerebral cortex, caudate putamen, globus pallidus, entopeduncular nucleus, subthalamic nucleus and substantia nigra pars reticulata ipsilateral to the lesion. This increased [3H]AA incorporation likely reflects disinhibition of basal ganglia and cortical circuits secondary to absent inhibitory nigrostriatal dopaminergic input.lld:pubmed
pubmed-article:9757030pubmed:languageenglld:pubmed
pubmed-article:9757030pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9757030pubmed:citationSubsetIMlld:pubmed
pubmed-article:9757030pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9757030pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9757030pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9757030pubmed:statusMEDLINElld:pubmed
pubmed-article:9757030pubmed:monthOctlld:pubmed
pubmed-article:9757030pubmed:issn0006-8993lld:pubmed
pubmed-article:9757030pubmed:authorpubmed-author:HayakawaTTlld:pubmed
pubmed-article:9757030pubmed:authorpubmed-author:BellJ MJMlld:pubmed
pubmed-article:9757030pubmed:authorpubmed-author:ChangM CMClld:pubmed
pubmed-article:9757030pubmed:authorpubmed-author:RapoportS ISIlld:pubmed
pubmed-article:9757030pubmed:authorpubmed-author:AppelN MNMlld:pubmed
pubmed-article:9757030pubmed:authorpubmed-author:SeemanRRlld:pubmed
pubmed-article:9757030pubmed:copyrightInfoCopyright 1998 Elsevier Science B.V.lld:pubmed
pubmed-article:9757030pubmed:issnTypePrintlld:pubmed
pubmed-article:9757030pubmed:day5lld:pubmed
pubmed-article:9757030pubmed:volume807lld:pubmed
pubmed-article:9757030pubmed:ownerNLMlld:pubmed
pubmed-article:9757030pubmed:authorsCompleteYlld:pubmed
pubmed-article:9757030pubmed:pagination177-81lld:pubmed
pubmed-article:9757030pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:9757030pubmed:meshHeadingpubmed-meshheading:9757030-...lld:pubmed
pubmed-article:9757030pubmed:meshHeadingpubmed-meshheading:9757030-...lld:pubmed
pubmed-article:9757030pubmed:meshHeadingpubmed-meshheading:9757030-...lld:pubmed
pubmed-article:9757030pubmed:meshHeadingpubmed-meshheading:9757030-...lld:pubmed
pubmed-article:9757030pubmed:meshHeadingpubmed-meshheading:9757030-...lld:pubmed
pubmed-article:9757030pubmed:meshHeadingpubmed-meshheading:9757030-...lld:pubmed
pubmed-article:9757030pubmed:meshHeadingpubmed-meshheading:9757030-...lld:pubmed
pubmed-article:9757030pubmed:meshHeadingpubmed-meshheading:9757030-...lld:pubmed
pubmed-article:9757030pubmed:meshHeadingpubmed-meshheading:9757030-...lld:pubmed
pubmed-article:9757030pubmed:meshHeadingpubmed-meshheading:9757030-...lld:pubmed
pubmed-article:9757030pubmed:meshHeadingpubmed-meshheading:9757030-...lld:pubmed
pubmed-article:9757030pubmed:meshHeadingpubmed-meshheading:9757030-...lld:pubmed
pubmed-article:9757030pubmed:meshHeadingpubmed-meshheading:9757030-...lld:pubmed
pubmed-article:9757030pubmed:meshHeadingpubmed-meshheading:9757030-...lld:pubmed
pubmed-article:9757030pubmed:meshHeadingpubmed-meshheading:9757030-...lld:pubmed
pubmed-article:9757030pubmed:meshHeadingpubmed-meshheading:9757030-...lld:pubmed
pubmed-article:9757030pubmed:meshHeadingpubmed-meshheading:9757030-...lld:pubmed
pubmed-article:9757030pubmed:meshHeadingpubmed-meshheading:9757030-...lld:pubmed
pubmed-article:9757030pubmed:year1998lld:pubmed
pubmed-article:9757030pubmed:articleTitleFatty acid incorporation depicts brain activity in a rat model of Parkinson's disease.lld:pubmed
pubmed-article:9757030pubmed:affiliationLaboratory of Neurosciences, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892-1582, USA.lld:pubmed
pubmed-article:9757030pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9757030lld:pubmed